INO – inovio pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Inovio Pharmaceuticals (NASDAQ:INO) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
INOVIO to Participate in December Investor Conferences
Individual investors invested in Inovio Pharmaceuticals, Inc. (NASDAQ:INO) lost 13% last week, institutions remained on the sidelines [Yahoo! Finance]
Inovio Pharmaceuticals (NASDAQ:INO) had its "overweight" rating reaffirmed by analysts at UBS Group AG.
Inovio Pharmaceuticals (NASDAQ:INO) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Form SCHEDULE 13G INOVIO PHARMACEUTICALS, Filed by: FMR LLC
Form SCHEDULE 13G INOVIO PHARMACEUTICALS, Filed by: Alyeska Investment Group, L.P.
Form SCHEDULE 13G INOVIO PHARMACEUTICALS, Filed by: JANUS HENDERSON GROUP PLC
Form SCHEDULE 13G/A INOVIO PHARMACEUTICALS, Filed by: Deep Track Capital, LP
Form SCHEDULE 13G INOVIO PHARMACEUTICALS, Filed by: Adage Capital Management, L.P.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.